This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Accuray Identifies EIMEA Region As Growth Territory

Stocks in this article: ARAY

SUNNYVALE, Calif., April 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in adoption of its CyberKnife® and TomoTherapy® Systems in Europe, India, the Middle East and Africa (EIMEA).

Accuray has expanded its installed base in the EIMEA region; Accuray radiation therapy systems have been used to treat more than 45,000 patients in EIMEA, further positioning the company as a global leader in precise, innovative radiation oncology.

The World Health Organization (WHO) World Cancer Report 2014 revealed that the cancer burden is growing at an alarming pace, with the number of annual new cancer cases expected to reach 22 million by 2035, a substantial increase from the current rate of 14 million new cases per year.

Europe is a region showing consistent and sustained growth for Accuray, with a high number of treatment centers that have two CyberKnife Systems at the same location, including Erasmus MC - Daniel den Hoed Cancer Center ( Rotterdam, Netherlands), Ospedale Civile San Bortolo (Vicenza, Italy) and Centro Diagnostico Italiano (CDI) ( Milan, Italy) as examples. Centers with at least one CyberKnife and one TomoTherapy System are also growing, including Oscar Lambret Cancer Center ( Lille, France), Antoine Lacassagne Cancer Center ( Nice, France), Leon Berard Cancer Center ( Lyon, France), Francois Baclesse Cancer Center (Caen, France), Charite University Hospital ( Berlin, Germany) and Gliwice University Hospital (Gliwice, Poland) as examples.

Additional 2013 EIMEA growth highlights include:

  • The first CyberKnife® M6™ Series installations in France in the public and private sectors (Centre Eugene Marquis, Rennes, and Centre Hartmann, Levallois-Perret)
  • The first CyberKnife M6 Series installation in Luxembourg
  • The first CyberKnife System installation in Ireland
  • The first TomoTherapy® H™ Series  installation in Sri Lanka
  • The first TomoTherapy installation in Greece (Iatropolis) making it the only center country-wide to offer both CyberKnife and TomoTherapy treatment
  • The first TomoTherapy System installation in Russia

"The CyberKnife and TomoTherapy Systems are widely recognized by the global oncology community as precise, innovative tumor treatments covering the full spectrum of radiation oncology cases," said Lionel Hadjadjeba, general manager for EIMEA and senior vice president international business at Accuray.  "These installation milestones reflect the increased adoption of our technologies throughout the world as we strive to optimize cancer care and enhance patient quality of life."

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs